Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
CardioNerds @AHA23: ORBITA-2: PCI for Stable Angina
Author(s): Rasha Al-Lamee , Christopher Rajkumar , Nazli Okumus Added: 5 months ago
AHA 2023 — Investigators of ORBITA-2 trial, Dr Rasha Al-Lamee and Dr Christopher Rajkumar (Imperial College London, UK) talked with CardioNerds Ambassador, Dr Nazli Okumus about the randomised, placebo-controlled trial (NCT03742050) that compared the effects of coronary angioplasty versus placebo procedure on symptoms of stable angina without background anti-anginal therapy at 12 weeks.The ORBITA… View more

Intervention
Author(s): Tim P van de Hoef , Werner Mohl , Ahmed A Khattab , et al Added: 3 years ago
Fast and effective opening of epicardial arteries by thrombolysis or percutaneous coronary intervention (PCI) to restore perfusion to the jeopardised myocardium is considered the cornerstone in the treatment of patients with an acute ST-elevation myocardial infarction (STEMI) leading to a reduction in morbidity and mortality.1 However, despite successful opening of the coronary artery, myocardial… View more

Intervention

MI/ACS
Author(s): Matthew Jackson , Azfar Zaman Added: 3 years ago
Medical therapy has been the primary treatment for stable angina since nitroglycerin was first used in 1878. However, since the first successful percutaneous coronary intervention (PCI) procedure was performed in 1977, the role of PCI in patients with stable coronary artery disease (CAD) has been the subject of much study. Numerous trials have shown no reduction in death or myocardial infarction… View more

Prevention & Chronic Conditions
AHA 2023 CardioNerds Conference Scholars Late-Breaking Video Collection
Author(s): Mandeep Mehra , Christian Inchaustegui Added: 5 months ago
In 2023, we are excited to partner with @CardioNerds, a dynamic team dedicated to democratizing cardiovascular education. Experience a fresh perspective on the new data through an interview series featuring principal investigators and ambassadors from the CardioNerds family.These interviews are supported by an educational grant from Novo Nordisk Inc. This content is not intended for UK HCPs. View more

Vascular Disease and Surgery

Heart Failure
Watch Now
Author(s): Pascal Vranckx Added: 1 year ago
This patient case study is part of the programme 'Individualising Antithrombotic Strategies for Established CAD'. In this short video, Prof Pascal Vranckx (Hartcentrum Hasselt, BE) presents a complex 62-year old male with stable angina and HFrEF, undergoing an elective angiography.Watch this case presentation and vote on what the optimal anti-platelet strategy is for this patient. … View more

Intervention
EuroPCR 2018: GZ-FFR Randomized Controlled Trial Of PCI Vs OMT - Dr Barry Hennigan
Author(s): Barry Hennigan Added: 5 years ago
Dr Barry Hennigan (Glasgow, UK) discusses The GZ FFR Study - Randomized Controlled Trial of PCI vs OMT in Patients with Stable Angina and Grey-Zone Fractional Flow Reserve Values. Filmed by Radcliffe Cardiology on-site at EuroPCR 2018 in Paris, FR. View more

Imaging & Diagnostics

Prevention & Chronic Conditions
View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 5 months ago
What's hot at #AHA23?Join Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) as they review the late-breaking science data from AHA Scientific Sessions 2023.They interpret the evidence from five key trials, providing context, asking thought-provoking questions to translate the data into key take-home messages for practice and research.Trials Covered00:20 - DAPA… View more

Anticoagulation

Standards & Guidelines
Percutaneous Coronary Intervention in Older People
Author(s): Sami A Omar , Adam de Belder Added: 3 years ago
There will be guidelines about the optimal management of most clinical situations. It makes decision making in medicine more universal, but often you have to think about all of the awkward situations that sit outside the guidelines. One neglected area of research involves the management of illness in older people. The older patient is often not included in trial protocols, and so a well of… View more

Vascular Disease and Surgery

Imaging & Diagnostics
Sotiris Antoniou, Consultant Pharmacist
Research Area(s) / Expertise:

Anticoagulation

Stroke Prevention in Atrial Fibrillation

 Job title: Consultant Pharmacist & Lead Cardiovascular Pharmacist
Mr Sotiris Antoniou is Consultant Pharmacist at Barts Heart Centre, part of Barts Health NHS Trust. Combined with his role as Lead Cardiovascular Pharmacist for UCL Partners supports medicines optimisation across the health economy to optimise patient outcomes and address unmet local needs. He is an independent prescriber and is currently chair of the cardiac committee for United Kingdom Clinical… View more
Foreword

Article

Author(s): Simon Kennon Added: 3 years ago
2017 and all that. The 2017 ESC/EACTS Guidelines for the management of valvular heart disease1 and in particular the recommendations with regard to choice of intervention mode for the treatment of aortic stenosis, may effect more change in cardiology treatment algorithms than most original research published in 2017, marking as they do, a significant shift towards transcatheter aortic valve… View more

Intervention